ALSAC Strengthens Executive Team for Future Growth
In a bold move to enhance its fundraising capabilities, ALSAC has appointed new leaders with substantial experience to its executive team. These experienced professionals will play pivotal roles as ALSAC continues its mission to support St. Jude Children's Research Hospital.
Meet the New Chief Marketing and Brand Officer
Samantha Maltin, a seasoned marketing strategist, joins ALSAC as the Chief Marketing and Brand Officer. With a wealth of experience in the nonprofit sector, she was previously the Executive Vice President at Sesame Workshop. Maltin has a remarkable history of brand leadership and strategy, having worked at organizations like Nickelodeon and the History Channel.
In her new position, she is committed to leveraging her expertise to promote the mission and values of St. Jude, ensuring that the hospital’s message resonates with supporters while encouraging deeper connections. Maltin expressed her excitement about joining ALSAC, emphasizing the importance of storytelling in inspiring compassion and support.
Introducing the Chief Data and Analytics Officer
Joining Maltin is Ankur Jain, who takes on the role of Chief Data and Analytics Officer. Jain, who has an extensive background in data science and analytics, previously held the position of Vice President at Whole Foods Market under Amazon. His expertise in AI and personalized experiences will be central to enhancing ALSAC’s outreach and engagement strategies.
Jain’s role at ALSAC will involve utilizing data to provide tailored experiences for the millions who support St. Jude. He is passionate about the mission driven by ALSAC and deeply understands the impact that effective data-driven strategies can have in raising awareness and funds for critical pediatric care.
Leadership Voices on New Appointments
Richard C. Shadyac Jr., the President and CEO of ALSAC, commented on the appointments, highlighting how Maltin and Jain embody the commitment needed to innovate within the organization. Their leadership will be key to constructing future fundraising strategies that resonate in today's rapidly evolving landscape.
Shadyac expressed confidence that their combined experiences and insights will contribute significantly to the growth and ongoing success of ALSAC and St. Jude, allowing them to meet supporters where they are at in this dynamic world.
The Vision for St. Jude Children’s Research Hospital
St. Jude is currently implementing a strategic plan worth $12.9 billion to expand its global outreach and enhance its capabilities to treat childhood cancer and other devastating diseases. This endeavor is anticipated to create around 2,500 new job opportunities within ALSAC and St. Jude, reflecting their commitment to expansion and excellence.
With a storied history since its inception in 1962, St. Jude has become a beacon of hope, pushing the survival rate for childhood cancer from a mere 20% to over 80%. Their unique model guarantees families do not receive bills for treatment, housing, travel, or food, allowing them to focus entirely on care for their children.
Frequently Asked Questions
What is ALSAC's main mission?
ALSAC's primary mission is to raise funds and awareness for St. Jude Children's Research Hospital, which is dedicated to treating and curing childhood cancer and other life-threatening diseases.
Who are the newly appointed officers at ALSAC?
Samantha Maltin has joined as Chief Marketing and Brand Officer, and Ankur Jain as Chief Data and Analytics Officer, both bringing significant expertise to the organization.
What significant achievements has St. Jude made in treating childhood cancer?
Since its founding in 1962, St. Jude has improved the survival rate for childhood cancer from 20% to over 80%, making considerable advancements in pediatric care.
How does St. Jude support families?
St. Jude provides treatment, housing, travel, and food at no cost to families, offering a supportive environment that allows them to focus solely on their child's health.
What does the strategic plan involve for ALSAC and St. Jude?
The strategic plan, valued at $12.9 billion, aims to expand treatment capabilities and services globally, including creating thousands of job opportunities over the coming decade.
